CH619718A5 - - Google Patents
Download PDFInfo
- Publication number
- CH619718A5 CH619718A5 CH321077A CH321077A CH619718A5 CH 619718 A5 CH619718 A5 CH 619718A5 CH 321077 A CH321077 A CH 321077A CH 321077 A CH321077 A CH 321077A CH 619718 A5 CH619718 A5 CH 619718A5
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- compound
- action
- diastereoisomers
- subjects
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/007—3 membered carbocyclic rings in position 6-7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/005—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7607476A FR2344286A1 (fr) | 1976-03-16 | 1976-03-16 | Nouveaux derives 17-spirosultines, les g-hydroxy acides correspondants, leur procede de preparation et leur application comme medicament |
Publications (1)
Publication Number | Publication Date |
---|---|
CH619718A5 true CH619718A5 (ko) | 1980-10-15 |
Family
ID=9170470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH321077A CH619718A5 (ko) | 1976-03-16 | 1977-03-15 |
Country Status (10)
Country | Link |
---|---|
US (1) | US4093720A (ko) |
JP (1) | JPS52136156A (ko) |
BE (1) | BE852457A (ko) |
CA (1) | CA1096857A (ko) |
CH (1) | CH619718A5 (ko) |
DE (1) | DE2711516C2 (ko) |
DK (1) | DK142681B (ko) |
FR (1) | FR2344286A1 (ko) |
GB (1) | GB1532734A (ko) |
NL (1) | NL7702757A (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2569408B1 (fr) * | 1984-08-24 | 1986-10-03 | Roussel Uclaf | Nouveaux steroides substitues en position 10 par un radical comportant une double ou triple liaison, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant |
JPS63193059U (ko) * | 1987-05-30 | 1988-12-13 | ||
JPH02106265U (ko) * | 1989-02-10 | 1990-08-23 | ||
FR2681069B1 (fr) * | 1991-09-06 | 1995-04-28 | Roussel Uclaf | Nouveau procede de preparation de l'hydrocortisone et nouveaux intermediaires. |
US6043235A (en) * | 1999-07-21 | 2000-03-28 | Research Triangle Institute | 11β-aryl-17, 17-spirothiolane-substituted steroids |
CN116925169A (zh) * | 2023-07-20 | 2023-10-24 | 浙江朗华制药有限公司 | 一种甾体化合物及其制备方法以及在坎利酮和螺内酯杂质研究中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD80023A (ko) * | ||||
US3383282A (en) | 1965-04-07 | 1968-05-14 | Upjohn Co | 7alpha-methyl-3, 5-androstadiene-3, 17-diols and pharmaceutically active compositions thereof |
DE2264189C3 (de) * | 1972-12-29 | 1979-05-31 | Merck & Co., Inc., Rahway, N.J. (V.St.A.) | 3'-(3-Oxo-17beta-hydroxy-6,7-methylen-androst-4en-bzw.-l,4-dien-17 a-yl) -propionsäureverbindungen, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Mittel |
FR2216276B1 (ko) | 1973-02-06 | 1976-11-05 | Roussel Uclaf | |
FR2285137A1 (fr) * | 1974-09-18 | 1976-04-16 | Roussel Uclaf | Nouveaux derives steroides 17-spirosultines, les g-hydroxyacides correspondants, leur procede de preparation et leur application comme medicament |
-
1976
- 1976-03-16 FR FR7607476A patent/FR2344286A1/fr active Granted
-
1977
- 1977-03-14 US US05/776,942 patent/US4093720A/en not_active Expired - Lifetime
- 1977-03-15 BE BE175786A patent/BE852457A/xx not_active IP Right Cessation
- 1977-03-15 DK DK112277AA patent/DK142681B/da unknown
- 1977-03-15 CA CA273,988A patent/CA1096857A/fr not_active Expired
- 1977-03-15 NL NL7702757A patent/NL7702757A/xx not_active Application Discontinuation
- 1977-03-15 CH CH321077A patent/CH619718A5/fr not_active IP Right Cessation
- 1977-03-15 JP JP2767577A patent/JPS52136156A/ja active Granted
- 1977-03-16 GB GB11177/77A patent/GB1532734A/en not_active Expired
- 1977-03-16 DE DE2711516A patent/DE2711516C2/de not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE2711516C2 (de) | 1987-03-05 |
DK142681B (da) | 1980-12-15 |
CA1096857A (fr) | 1981-03-03 |
FR2344286B1 (ko) | 1978-11-17 |
US4093720A (en) | 1978-06-06 |
JPS52136156A (en) | 1977-11-14 |
BE852457A (fr) | 1977-09-15 |
DE2711516A1 (de) | 1977-09-22 |
NL7702757A (nl) | 1977-09-20 |
DK142681C (ko) | 1981-08-03 |
DK112277A (ko) | 1977-09-17 |
JPS6126557B2 (ko) | 1986-06-20 |
FR2344286A1 (fr) | 1977-10-14 |
GB1532734A (en) | 1978-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2584725A1 (fr) | Androsta-1,4-diene-3,17-diones substituees, leur procede de fabrication et medicaments les contenant | |
EP0310519B1 (fr) | Nouveaux esters d'acide androstane 17-carboxylique, procédé pour leur préparation et médicament les contenant | |
EP0056000B1 (fr) | Dérivés 17/(alkoxycarbonyle) (formamido) méthylène/stéroides et leur préparation | |
EP0082049A2 (fr) | Nouveaux éthers dont les restes organiques comportent des atomes chiraux, leur préparation, leur application au dédoublement d'alcools ou de certains composés hémiacétaliques et les nouveaux produits dédoublés obtenus | |
CH619718A5 (ko) | ||
JPS59139400A (ja) | 抗アルドステロン活性ステロイド誘導体 | |
EP0001029B1 (fr) | Procédé de préparation d'oximes en 3 de stéroides | |
CA1051419A (fr) | Procede de preparation de nouveaux derives steroidiques | |
EP0012641B1 (fr) | Dérivés 2-substitués du 19-nor-pregn-4-ène-3,20-dione, procédé pour leur préparation et compositions pharmaceutiques les renfermant | |
EP0018245B1 (fr) | Nouveaux dérivés stéroides 7-alkylés, leur procédé de préparation, leur application comme médicament et les compositions pharmaceutiques les renfermant | |
EP0275728B1 (fr) | Nouveaux produits stéroîdes comportant, en position 23, un radical sulfinyle, leur procédé de préparation, leur application à la préparation de produits de la série des 20-cétoprégnanes et des intermédiaires de cette application | |
CA1096372A (fr) | Procede de preparation de nouveaux 2,2-dimethyl 19- nor steroides | |
CA1072540A (fr) | Procede de preparation de nouveaux 2,2-dimethyl steroides | |
EP0055170B1 (fr) | Nouveaux dérivés stéroides 3-céto delta 4 ou delta 1-4 substitués en position 7, leur préparation, leur application comme médicaments et les compositions les renfermant | |
EP0059146B1 (fr) | Nouveaux médicaments dérivés de la 3-hydroxy dodécahydro benz (e) inden-7-one, produits dérivés de la 3-hydroxy dodécahydro benz (e) inden-7-one et leur procédé de préparation | |
CH627193A5 (ko) | ||
EP0058097A2 (fr) | Nouveau procédé de préparation de 17alpha-hydroxy 17bêta-hydroxyacétyl stéroides et produits intermédiaires correspondants obtenus | |
EP0000300A1 (fr) | Estra-1,3,5(10),6-tétraènes substitués, procédé de préparation et application dans la synthèse de stéroides marqués au tritium | |
CH633714A5 (fr) | Derives 17alpha-acetyleniques de l'androst 4-ene, procede de prepararation et compositions pharmaceutiques. | |
EP0375559B1 (fr) | Nouveaux produits stéroides comportant un radical alkylthio en position 4, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant | |
CH629826A5 (en) | Steroids, process for preparing them and their use in the synthesis of tritium-labelled steroids | |
EP0016665B1 (fr) | Procédé de préparation de dérivés de la xanthone | |
FR2600254A1 (fr) | Derives methylenes des androstene-4 diones-3, 17, leur procede de preparation, et leur application comme medicaments | |
CA1326235C (fr) | Composes steroides utiles pour la preparation de produits de la serie 20-ceto pregnane | |
FR2478106A1 (fr) | Nouveaux derives de steroide-spiro-oxathiazolidine, leur procede de preparation et medicaments les contenant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |